Effects of Mediyoga in Patients With Paroxysmal Atrial Fibrillation
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The purpose of this study is to determinate if mediyoga has effects in quality of life, heart rate variability, blood pressure , heart rate in patients with paroxysmal atrial fibrillation (PAF).
| Condition |
|---|
|
Paroxysmal Atrial Fibrillation |
| Study Type: | Observational |
| Study Design: | Observational Model: Case Control Time Perspective: Prospective |
| Official Title: | Effects of Mediyoga in Patients With Paroxysmal Atrial Fibrillation |
- Quality of life [ Time Frame: Change from baseline in SF-36 after 12 weeks.Change from baseline in SF-36 after six months. ] [ Designated as safety issue: No ]
- Quality of life [ Time Frame: Change from baseline in SF-36 after 12 weeks.Change from baseline in EQ-5D after six month ] [ Designated as safety issue: No ]
- Blood pressure [ Time Frame: Change from baseline in blood pressure after 12 weeks. Change from baseline in blood pressure after six months ] [ Designated as safety issue: No ]
- heart rate [ Time Frame: Change from baseline in heart rate after 12 weeks.Change from baseline in heart rate after six months. ] [ Designated as safety issue: No ]
- Heart variability [ Time Frame: Change from baseline in heart variability after 12 weeks.Change from baseline in heart variability after six months. ] [ Designated as safety issue: No ]
| Enrollment: | 80 |
| Study Start Date: | December 2009 |
| Study Completion Date: | June 2012 |
| Primary Completion Date: | June 2012 (Final data collection date for primary outcome measure) |
This is randomized prospective pilot study. Eighty patients from Danderyd hospital, Stockholm, Sweden were randomized to either mediyoga group or control group. The mediyoga group were completing yoga for one hour, once a week for 12 weeks together with usual treatment. The controlgroup had only usual treatment.The usual treatment consists of pharmaceutical, cardio version and ablation. Quality of life ( SF-36, EQ-5d), blood pressure, heart rate and 24-hours ekokardiografi were measured at baseline and after twelve weeks.A follow up after six months was accomplished with SF-36 and EQ-5d, bloodpressure and heart rate.
Eligibility| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Non-Probability Sample |
Primary care clinic. All participants should have been on usual treatment (medication, cardio version or ablation) for at least three months.
Inclusion Criteria:
- Diagnosis of PAF
Exclusion Criteria:
- The exclusions criteria were multiple concurrent medical conditions and/or cognitive dysfunction (in the diagnosis of e.g. mental illness), considered not to be able to carry out yoga owing to ability to move and those who have difficulties to understand the Swedish language.
Contacts and LocationsPlease refer to this study by its ClinicalTrials.gov identifier: NCT01789372
| Sweden | |
| Danderyds hospital | |
| Stockholm, Sweden, 182 88 | |
| Study Director: | Viveka Frykman, Phd, MD | Danderyd hospital, Karolinska Institute Sweden |
More Information
No publications provided
| Responsible Party: | Maria Nilsson, Reg nurse, Danderyd Hospital |
| ClinicalTrials.gov Identifier: | NCT01789372 History of Changes |
| Other Study ID Numbers: | YOGAFF-001 |
| Study First Received: | February 5, 2013 |
| Last Updated: | February 11, 2013 |
| Health Authority: | Sweden: Regional Ethical Review Board |
Keywords provided by Danderyd Hospital:
|
paroxysmal atrial fibrillation yoga quality of life |
blood pressure heart rate heart rate variability |
Additional relevant MeSH terms:
|
Atrial Fibrillation Arrhythmias, Cardiac Cardiovascular Diseases Heart Diseases Pathologic Processes |
ClinicalTrials.gov processed this record on March 03, 2015